Fmoc-AEEA

Fmoc-AEEA is a peptide building block used in peptide synthesis. It is an Fmoc-protected amino acid with an alpha-ethyl-ε-caprolactam side chain. Fmoc-AEEA is used in the synthesis of peptides that have specific physical properties, such as increased solubility, flexibility, and stability.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Fmoc-AEEA(CAS 166108-71-0)

CAT No: 10-101-236

CAS No:166108-71-0

Synonyms/Alias:166108-71-0;[2-[2-(Fmoc-amino)ethoxy]ethoxy]acetic acid;Fmoc-NH-PEG2-CH2COOH;1-(9H-FLUOREN-9-YL)-3-OXO-2,7,10-TRIOXA-4-AZADODECAN-12-OIC ACID;8-(Fmoc-amino)-3,6-dioxaoctanoic acid;Fmoc-8-amino-3,6-dioxaoctanoic acid;FMOC-AEEAC-OH;{2-[2-(Fmoc-amino)ethoxy]ethoxy}acetic acid;MFCD01321015;3,6,11-TRIOXA-9-AZADODECANOIC ACID, 12-(9H-FLUOREN-9-YL)-10-OXO-;FMOC-AMINO-3,6 DIOXAOCTANOIC ACID;8-(9-Fluorenylmethoxycarbonylamino)-3,6-dioxaoctanoic acid;8-(9-FLUORENYLMETHYLOXYCARBONYL-AMINO)-3,6-DIOXAOCTANOIC ACID;[2-(2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}ethoxy)ethoxy]acetic acid;2-{2-[2-({[(9H-FLUOREN-9-YL)METHOXY]CARBONYL}AMINO)ETHOXY]ETHOXY}ACETIC ACID;2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]acetic Acid;Fmoc-Adoa-OH;8-(Fmoc-amino)-3,6-dioxa-octanoic acid;{2-[2-(Fmoc-amino)-ethoxy]-ethoxy}-acetic acid;Fmoc-8-amino-3,6-dioxa-octanoic acid;Fmoc-AEEA-OH;[2-(2-(Fmoc-amino)ethoxy)ethoxy]acetic acid;2-(2-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)ethoxy)acetic acid;Fmoc-mini-PEG;Fmoc-AEEA; 12-(9H-Fluoren-9-yl)-10-oxo-3,6,11-trioxa-9-azadodecanoic Acid; 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-12-oic Acid; 8-(9-Fluorenylmethoxycarbonylamino)-3,6-dioxaoctanoic Acid; 9-Fluorenylmethoxycarbonyl-8-amino-3,6-dioxaoctanoic Acid;FMOC-ADOA;2,7,10-Trioxa-4-azadodecan-12-oic acid, 1-(9H-fluoren-9-yl)-3-oxo-;8-[(9H-Fluoren-9-ylmethoxy)carbonylamino]-3,6-dioxa-n-octanoic Acid;[2-[2-[(Fmoc-amino)ethoxy]ethoxy]acetic Acid;SCHEMBL259018;FXX-5521-PI;DTXSID50373231;BCP11185;TD8147;AKOS015840985;AB09039;CS-W007713;FF35496;HY-W007713;AC-26584;AS-17641;BP-22044;SY017426;DB-013693;{2[2-(Fmoc-amino)ethoxy]ethoxy}acetic acid;8-(Fmoc-amino)-3,6-dioxa-n-octanoic Acid;F0719;2-[2-[2-(Fmoc-amino)ethoxy]ethoxy]acetic acid;EN300-1556421;Fmoc-mini-PEG Fmoc-8-Amino-3,6-Dioxaoctanoic Acid;{2-[2-(Fmoc-amino)ethoxy]ethoxy}acetic acid, >=95.0% (HPLC);(2-(2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy)ethoxy)acetic acid;[2-[2-[(9H-Fluoren-9-ylmethoxy)carbonylamino]ethoxy]ethoxy]acetic Acid;2-[2-(2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}ethoxy)ethoxy]acetic acid;805-205-6;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C21H23NO6
M.W/Mr.
385.4
Application
{2-[2-(Fmoc-amino)ethoxy]ethoxy}acetic acid is a heterobifunctional, hydrophilic spacer

Fmoc-AEEA, also known as 9-fluorenylmethyloxycarbonyl-aminoethoxyethoxyacetic acid, is a versatile and widely utilized linker in peptide and oligonucleotide synthesis. Renowned for its unique structural properties, this bifunctional compound features both the Fmoc protecting group and an ethylene glycol-based spacer, which collectively facilitate the controlled assembly of complex biomolecules. Its design enables increased flexibility and solubility, making it especially valuable in synthetic protocols that require precise spatial arrangement and reduced steric hindrance. The presence of the Fmoc group allows for straightforward deprotection using mild bases, while the AEEA spacer introduces hydrophilicity and optimal distance between functional moieties. As a result, Fmoc-AEEA has become an indispensable tool in the development of advanced research reagents, supporting innovation in fields ranging from chemical biology to drug discovery.

Peptide Synthesis: In solid-phase peptide synthesis, the utilization of Fmoc-AEEA as a linker or spacer is highly advantageous for constructing peptide chains with enhanced conformational freedom. The ethylene glycol-based AEEA unit imparts increased flexibility to the growing peptide, mitigating aggregation and promoting efficient chain elongation. By incorporating this linker, researchers can design peptides with unique structural motifs, optimize sequence accessibility, and improve overall synthesis yields. The Fmoc group ensures compatibility with standard Fmoc/t-Bu strategies, allowing seamless integration into established synthetic workflows.

Oligonucleotide Conjugation: Fmoc-AEEA plays a pivotal role in the conjugation of oligonucleotides to a variety of biomolecules, including peptides, fluorophores, and other functional groups. Its hydrophilic spacer reduces steric crowding at the conjugation site, thereby enhancing the efficiency and specificity of coupling reactions. By introducing the AEEA linker, oligonucleotide conjugates benefit from improved solubility and reduced non-specific interactions, which is particularly important in the development of molecular probes and nucleic acid-based sensors for research applications.

Bioconjugation Strategies: The application of 9-fluorenylmethyloxycarbonyl-aminoethoxyethoxyacetic acid extends to bioconjugation protocols that require precise spatial orientation between biomolecular components. The flexible and hydrophilic nature of the AEEA spacer allows for the creation of multifunctional bioconjugates with tailored properties, such as enhanced binding affinity or selective recognition. Researchers leverage this compound to construct well-defined protein-peptide, peptide-drug, or peptide-dye conjugates, facilitating studies in molecular recognition, signal transduction, and targeted delivery.

Surface Modification: In the realm of surface chemistry, Fmoc-AEEA is frequently utilized to functionalize solid supports, such as resins, nanoparticles, or biosensor surfaces. The incorporation of the AEEA spacer provides a means to control the density and orientation of immobilized molecules, minimizing steric hindrance and promoting optimal interaction with analytes or biological targets. This approach is instrumental in the fabrication of high-performance biosensors, affinity matrices, and diagnostic platforms, where precise molecular presentation is critical for sensitivity and specificity.

Combinatorial Library Construction: The use of Fmoc-AEEA in combinatorial chemistry enables the generation of diverse molecular libraries for screening and discovery purposes. Its compatibility with automated synthesis platforms, coupled with the ability to introduce spatial separation between library members, supports the efficient identification of lead compounds or functional motifs. By leveraging the unique properties of the AEEA spacer, researchers can explore novel chemical space and accelerate the development of new research tools, ligands, or bioactive molecules for a wide range of scientific investigations.

Shipping Condition
Room temperature in continental US; may vary elsewhere.
InChI
InChI=1S/C21H23NO6/c23-20(24)14-27-12-11-26-10-9-22-21(25)28-13-19-17-7-3-1-5-15(17)16-6-2-4-8-18(16)19/h1-8,19H,9-14H2,(H,22,25)(H,23,24)
InChI Key
XQPYRJIMPDBGRW-UHFFFAOYSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOCustom Conjugation ServicePeptide Analysis ServicescGMP Peptide ServicePeptide Synthesis ServicesPeptide Nucleic Acids SynthesisEpitope Mapping ServicesPeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers